Bruce R. Blazar

2.5k total citations
43 papers, 1.9k citations indexed

About

Bruce R. Blazar is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Bruce R. Blazar has authored 43 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 24 papers in Immunology and 11 papers in Oncology. Recurrent topics in Bruce R. Blazar's work include Hematopoietic Stem Cell Transplantation (26 papers), T-cell and B-cell Immunology (13 papers) and Immunotherapy and Immune Responses (10 papers). Bruce R. Blazar is often cited by papers focused on Hematopoietic Stem Cell Transplantation (26 papers), T-cell and B-cell Immunology (13 papers) and Immunotherapy and Immune Responses (10 papers). Bruce R. Blazar collaborates with scholars based in United States, United Kingdom and Japan. Bruce R. Blazar's co-authors include Daniel A. Vallera, Patricia A. Taylor, Philip B. McGlave, N. K. C. Ramsay, Randolph J. Noelle, A.H. Filipovich, JH Kersey, Daniel Weisdorf, Wayne L. Miller and Norma K.C. Ramsay and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Immunity.

In The Last Decade

Bruce R. Blazar

42 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bruce R. Blazar United States	22	1.0k	958	366	209	173	43	1.9k
A Kanamaru Japan	25	785 0.8×	1.0k 1.1×	512 1.4×	531 2.5×	210 1.2×	84	2.1k
Y Takemoto Japan	21	358 0.4×	745 0.8×	259 0.7×	471 2.3×	132 0.8×	74	1.6k
Yuqian Sun China	28	620 0.6×	1.7k 1.8×	658 1.8×	221 1.1×	283 1.6×	200	2.7k
G. Del Toro United States	13	344 0.3×	341 0.4×	163 0.4×	481 2.3×	153 0.9×	25	1.6k
Abdul S. Rao United States	28	1.2k 1.2×	299 0.3×	254 0.7×	280 1.3×	71 0.4×	73	2.9k
Matthew J. Olnes United States	18	260 0.3×	890 0.9×	352 1.0×	243 1.2×	262 1.5×	42	1.6k
Robert Corringham United States	18	454 0.5×	451 0.5×	823 2.2×	494 2.4×	147 0.8×	35	1.9k
Michael Daskalakis Switzerland	18	151 0.2×	494 0.5×	245 0.7×	677 3.2×	177 1.0×	55	1.5k
Conrad A. Farrar United Kingdom	25	1.4k 1.4×	215 0.2×	68 0.2×	221 1.1×	158 0.9×	42	2.0k
Eeva von Willebrand Finland	26	542 0.5×	221 0.2×	115 0.3×	239 1.1×	97 0.6×	93	2.1k

Countries citing papers authored by Bruce R. Blazar

Since Specialization

Citations

This map shows the geographic impact of Bruce R. Blazar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce R. Blazar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce R. Blazar more than expected).

Fields of papers citing papers by Bruce R. Blazar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce R. Blazar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce R. Blazar. The network helps show where Bruce R. Blazar may publish in the future.

Co-authorship network of co-authors of Bruce R. Blazar

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce R. Blazar. A scholar is included among the top collaborators of Bruce R. Blazar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce R. Blazar. Bruce R. Blazar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dalvi, Pranjali, Kevin Dang, James P. Allison, et al.. (2025). Inhibition of CD38 enzyme activity on engrafted human immune cells enhances NAD+ metabolism and inhibits inflammation in an in-vivo model of xeno-GvHD. Frontiers in Immunology. 16. 1640611–1640611.

Zheng, Hengqi, Bruce A. Watkins, Victor Tkachev, et al.. (2016). The Knife’s Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism but With a Significant Risk of CMV Reactivation and Disease in Rhesus Macaques. American Journal of Transplantation. 17(3). 657–670. 17 indexed citations

Sckisel, Gail D., Myriam N. Bouchlaka, Arta M. Monjazeb, et al.. (2015). Out-of-Sequence Signal 3 Paralyzes Primary CD4+ T-Cell-Dependent Immunity. Immunity. 43(2). 240–250. 88 indexed citations

Murase, Kazuyuki, H. T. Kim, Yutaka Kawano, et al.. (2014). Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation. Haematologica. 99(9). 1499–1508. 16 indexed citations

Rogosheske, John, Todd E. DeFor, Erica D. Warlick, et al.. (2013). Higher therapeutic CsA levels early post transplantation reduce risk of acute GVHD and improves survival. Bone Marrow Transplantation. 49(1). 122–125. 31 indexed citations

Ramírez, Pablo, Jasenka Wagner, Todd E. DeFor, et al.. (2011). Factors predicting single-unit predominance after double umbilical cord blood transplantation. Bone Marrow Transplantation. 47(6). 799–803. 42 indexed citations

Wagner, Jasenka, Akemi Ishida‐Yamamoto, John A. McGrath, et al.. (2009). Adult stem cells for treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB). Journal of Investigative Dermatology. 129. 4 indexed citations

Blazar, Bruce R., Daniel J. Weisdorf, Todd E. DeFor, et al.. (2006). Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). Blood. 108(9). 3216–3222. 109 indexed citations

Zimmerman, Zachary, Angela M. Jones, Vadim Deyev, et al.. (2004). Perforin, FasL, TNFR1, TWEAK, TRAIL, and DR3-TL1a are not required for efficient T cell mediated resistance against allogeneic bone marrow grafts. Biology of Blood and Marrow Transplantation. 10. 39–39. 1 indexed citations

10.

Blazar, Bruce R., et al.. (2000). Opposing roles of interferon-gamma on CD4+ T cell-mediated graft-versus-host disease: Effects of conditioning. Biology of Blood and Marrow Transplantation. 6(6). 604–612. 63 indexed citations

11.

Blazar, Bruce R., Todd E. DeFor, Wesley J. Miller, et al.. (2000). A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease. Biology of Blood and Marrow Transplantation. 6(4). 441–447. 96 indexed citations

12.

Vallera, Daniel A., et al.. (1999). Targeting myeloid leukemia with a DT390-mIL-3 fusion immunotoxin: ex vivo and in vivo studies in mice. Protein Engineering Design and Selection. 12(9). 779–785. 13 indexed citations

13.

Sykes, Megan, Denise A. Pearson, Patricia A. Taylor, et al.. (1999). Dose and timing of interleukin (IL)-12 and timing and type of total-body irradiation: Effects on graft-vs.-host disease inhibition and toxicity of exogenous IL-12 in murine bone marrow transplant recipients. Biology of Blood and Marrow Transplantation. 5(5). 277–284. 37 indexed citations

14.

Blazar, Bruce R., Patricia A. Taylor, Randolph J. Noelle, & Daniel A. Vallera. (1998). CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses.. Journal of Clinical Investigation. 102(3). 473–482. 83 indexed citations

15.

Blazar, Bruce R., Patricia A. Taylor, Angela Panoskaltsis‐Mortari, et al.. (1997). Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. The Journal of Immunology. 158(1). 29–39. 151 indexed citations

16.

Blazar, Bruce R., Arlene H. Sharpe, Patricia A. Taylor, et al.. (1996). Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells. The Journal of Immunology. 157(8). 3250–3259. 88 indexed citations

17.

Katsanis, Emmanuel, Bruce R. Blazar, María A. Bausero, Roland Günther, & Peter M. Anderson. (1994). Retroperitoneal inoculation of murine neuroblastoma results in a reliable model for evaluation of the antitumor immune response. Journal of Pediatric Surgery. 29(4). 538–542. 11 indexed citations

18.

McClure, Joan S., Philip B. McGlave, N. K. C. Ramsay, et al.. (1994). Cyclophosphamide & total body irradiation versus busulfan & cyclophosphamide: A randomized comparison of 2 conditioning regimens in autologous bone marrow transplantation for acute myeloid leukemia. International Journal of Radiation Oncology*Biology*Physics. 30. 181–182. 6 indexed citations

19.

Phillips, J. P., Lawrence A. Lockman, Elsa Shapiro, et al.. (1994). CSF findings in adrenoleukodystrophy: Correlation between measures of cytokines, IgG production, and disease severity. Pediatric Neurology. 10(4). 289–294. 16 indexed citations

20.

Whitley, Chester B., Kumar G. Belani, Pi‐Nian Chang, et al.. (1993). Long‐term outcome of Hurler syndrome following bone marrow transplantation. American Journal of Medical Genetics. 46(2). 209–218. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact